| Lactose (India) Ltd | 126 Cr. | 100.0 | 231/84.3 | 27.8 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.54 Cr. | 1.85 | 4.29/1.76 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,735 Cr. | 436 | 479/192 | 98.0 | 24.3 | 0.15 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.4 Cr. | 43.7 | 88.6/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 52.1 Cr. | 35.6 | 36.4/17.0 | 124 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 57.7 Cr. | 76.7 | 119/69.7 | 15.6 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 57,361 Cr. | 2,030 | 2,286/1,275 | 22.8 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 353 Cr. | 14.5 | 19.0/10.8 | 21.2 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 18.0/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 758 Cr. | 1,605 | 1,999/635 | 26.2 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 98.0 Cr. | 19.6 | 32.0/17.0 | 26.8 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 1,029 Cr. | 350 | 449/219 | 9.19 | 133 | 0.72 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 3.49 Cr. | 16.6 | 39.0/15.2 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 8.34 Cr. | 3.35 | 8.28/2.11 | 4.74 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 475 Cr. | 489 | 517/211 | 71.8 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,374 Cr. | 1,006 | 1,565/944 | 39.6 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 57.3 Cr. | 0.28 | 1.12/0.24 | 3.77 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 44.4 Cr. | 16.9 | 26.3/11.4 | 21.7 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.32 Cr. | 9.23 | 17.2/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 156 Cr. | 437 | 859/431 | 8.85 | 596 | 0.34 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 86.0 Cr. | 86.0 | 92.5/26.1 | 162 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 14,021 Cr. | 1,341 | 2,452/1,315 | 43.6 | 174 | 0.80 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 23.0 Cr. | 50.3 | 88.7/36.1 | 49.9 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 13.4 Cr. | 5.38 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 16.4 Cr. | 109 | 152/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 59.5 Cr. | 109 | 114/9.41 | 41.0 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 31.4 Cr. | 41.6 | 80.0/33.0 | 50.6 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.60 Cr. | 22.0 | 25.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 9,027 Cr. | 520 | 1,028/512 | 25.6 | 72.4 | 0.23 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 87.1 Cr. | 20.2 | 35.9/18.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.5 Cr. | 22.7 | 43.0/17.4 | 50.1 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 88,860 Cr. | 2,152 | 2,998/2,090 | 53.3 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 241 Cr. | 418 | 524/241 | 24.7 | 123 | 1.08 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 48.7 Cr. | 34.0 | 54.3/26.7 | 76.1 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 68,964 Cr. | 1,186 | 1,365/994 | 20.2 | 603 | 0.34 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 153 Cr. | 245 | 303/159 | 145 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 806 Cr. | 80.0 | 117/74.0 | 20.8 | 32.6 | 1.87 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 38.1 Cr. | 29.2 | 46.0/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 13,538 Cr. | 1,656 | 1,902/919 | 60.4 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.29 Cr. | 0.65 | 1.33/0.51 | 107 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 219 Cr. | 28.5 | 60.0/26.0 | 14.0 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 5.39 Cr. | 9.21 | 21.1/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 128 Cr. | 5.42 | 6.57/2.82 | 297 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 60,926 Cr. | 28,680 | 37,000/25,260 | 40.4 | 1,888 | 1.66 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,759 Cr. | 747 | 972/557 | 28.2 | 226 | 0.67 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 196 Cr. | 68.0 | 100/31.3 | 54.6 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 5,059 Cr. | 1,525 | 1,740/752 | | 103 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 22,396 Cr. | 1,374 | 1,870/1,110 | 408 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 808 Cr. | 232 | 330/154 | 18.8 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 155 Cr. | 18.6 | 29.4/18.6 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 992 Cr. | 742 | 849/270 | 15.7 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,037 Cr. | 434 | 791/430 | 20.8 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,462 Cr. | 1,033 | 1,436/991 | 20.7 | 768 | 0.97 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,29,393 Cr. | 3,822 | 3,882/2,886 | 59.7 | 250 | 0.84 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 915 Cr. | 99.3 | 284/98.0 | | 41.3 | 0.50 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,324 Cr. | 14.1 | 23.5/14.0 | 21.1 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 20,186 Cr. | 528 | 1,328/518 | 58.8 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,815 Cr. | 167 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,12,662 Cr. | 1,720 | 1,910/1,547 | 35.8 | 324 | 0.93 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,457 Cr. | 551 | 734/441 | 383 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,949 Cr. | 314 | 335/175 | 36.4 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,168 Cr. | 316 | 502/265 | 39.9 | 125 | 0.16 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 9,012 Cr. | 206 | 260/111 | 208 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,359 Cr. | 4,064 | 6,718/4,050 | 25.3 | 340 | 2.88 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,735 Cr. | 2,285 | 2,725/1,772 | 33.5 | 335 | 0.88 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,375 Cr. | 5,652 | 6,739/4,904 | 30.6 | 373 | 2.21 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 164 Cr. | 46.6 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 22,549 Cr. | 4,927 | 5,993/3,701 | 31.9 | 841 | 0.71 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 122 Cr. | 99.4 | 220/81.0 | 12.6 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,361 Cr. | 387 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,820 Cr. | 752 | 1,998/604 | 73.1 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 19,175 Cr. | 14,929 | 19,748/10,060 | 97.9 | 1,263 | 0.08 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 414 Cr. | 18.5 | 41.4/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 16,067 Cr. | 897 | 1,420/660 | 10.4 | 483 | 0.67 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,216 Cr. | 40.5 | 80.7/38.4 | 29.4 | 21.8 | 0.49 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,135 Cr. | 180 | 308/162 | 23.1 | 59.3 | 0.45 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 41.4 Cr. | 26.2 | 130/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 270 Cr. | 75.2 | 167/72.2 | 132 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 95,151 Cr. | 2,080 | 2,403/1,774 | 22.0 | 430 | 0.58 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 954 Cr. | 478 | 872/464 | 11.9 | 357 | 0.38 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 58,855 Cr. | 1,091 | 1,098/501 | 86.2 | 91.1 | 0.11 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,152 Cr. | 1,110 | 1,235/596 | 23.5 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 147 Cr. | 69.1 | 114/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 726 Cr. | 150 | 219/123 | 41.2 | 104 | 2.00 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 604 Cr. | 345 | 500/265 | 21.9 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 16,637 Cr. | 1,041 | 1,250/802 | 33.5 | 414 | 0.48 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,195 Cr. | 1,800 | 1,918/1,303 | 39.2 | 243 | 0.86 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,291 Cr. | 193 | 302/191 | 29.5 | 38.0 | 1.30 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 35,189 Cr. | 1,386 | 1,758/1,168 | 35.6 | 293 | 0.29 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,356 Cr. | 80.2 | 127/57.5 | 20.3 | 59.7 | 1.00 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 733 Cr. | 89.7 | 124/67.2 | 24.7 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,092 Cr. | 231 | 350/190 | | 106 | 0.09 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,801 Cr. | 226 | 457/217 | 277 | 96.9 | 0.62 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,348 Cr. | 1,581 | 2,496/1,243 | 30.8 | 397 | 0.44 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,339 Cr. | 332 | 498/285 | 61.5 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 14,524 Cr. | 599 | 627/412 | 28.4 | 164 | 0.25 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 57,346 Cr. | 2,029 | 2,286/1,275 | 22.8 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 40,489 Cr. | 2,389 | 3,516/1,921 | 42.5 | 101 | 1.76 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 27,651 Cr. | 1,678 | 2,131/1,200 | 23.9 | 610 | 1.07 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,670 Cr. | 407 | 528/359 | 29.6 | 149 | 1.23 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 20,491 Cr. | 1,505 | 1,910/1,097 | 49.3 | 227 | 0.49 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,05,660 Cr. | 1,266 | 1,406/1,020 | 18.3 | 432 | 0.63 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,811 Cr. | 243 | 322/178 | 25.5 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,20,439 Cr. | 1,491 | 1,673/1,310 | 22.1 | 408 | 0.87 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 13,663 Cr. | 1,787 | 2,626/1,551 | 23.2 | 416 | 0.34 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 208 Cr. | 70.9 | 203/68.1 | 14.9 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,717 Cr. | 162 | 191/105 | 15.7 | 107 | 0.31 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 55.2 Cr. | 33.7 | 63.1/32.5 | 19.4 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 52,228 Cr. | 390 | 425/291 | 110 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,587 Cr. | 1,572 | 2,000/1,430 | 35.1 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 116 Cr. | 72.6 | 132/67.2 | 17.0 | 49.2 | 1.66 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 356 Cr. | 151 | 205/67.8 | 33.7 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,269 Cr. | 8,896 | 10,691/6,502 | 96.3 | 320 | 0.36 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,928 Cr. | 666 | 843/544 | 34.0 | 118 | 0.69 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 164 Cr. | 78.9 | 137/73.6 | 8.74 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 64,958 Cr. | 5,428 | 5,868/4,492 | 27.6 | 1,116 | 0.83 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 16,366 Cr. | 835 | 1,124/725 | 25.8 | 271 | 1.31 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 421 Cr. | 737 | 1,412/730 | | 690 | 0.68 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 33,847 Cr. | 2,706 | 3,094/2,022 | 34.8 | 345 | 1.04 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,367 Cr. | 301 | 367/258 | 22.8 | 133 | 1.72 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,748 Cr. | 409 | 575/312 | 19.7 | 147 | 0.24 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 19,996.96 Cr | 1,139.22 | | 52.85 | 202.18 | 0.36% | 16.29% | 15.20% | 6.10 |